SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

ACRS seeking new committee member

July 21, 2026, 10:07AMNuclear News

The Nuclear Regulatory Commission’s Advisory Committee on Reactor Safeguards (ACRS) is currently seeking qualified candidates to fill an open committee member position. Applications for the...